Is EOP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EOP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EOP (CHF53.59) is trading below our estimate of fair value (CHF161.33)
Significantly Below Fair Value: EOP is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EOP?
Key metric: As EOP is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for EOP. This is calculated by dividing EOP's market cap by their current
revenue.
What is EOP's PS Ratio?
PS Ratio
7.8x
Sales
US$1.25b
Market Cap
US$9.78b
EOP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: EOP is expensive based on its Price-To-Sales Ratio (7.8x) compared to the European Semiconductor industry average (1.8x).
Price to Sales Ratio vs Fair Ratio
What is EOP's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
EOP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
7.8x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate EOP's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst EOP forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
n/a
CHF 85.63
0%
24.8%
CHF 128.03
CHF 52.10
n/a
36
Nov ’25
n/a
CHF 91.84
0%
21.1%
CHF 133.44
CHF 62.39
n/a
36
Oct ’25
CHF 97.18
CHF 107.95
+11.1%
16.1%
CHF 143.87
CHF 69.40
n/a
36
Sep ’25
CHF 104.50
CHF 109.11
+4.4%
15.8%
CHF 144.75
CHF 69.82
n/a
38
Aug ’25
n/a
CHF 113.24
0%
15.0%
CHF 149.76
CHF 72.24
n/a
37
Jul ’25
n/a
CHF 115.75
0%
15.7%
CHF 148.25
CHF 63.41
n/a
37
Jun ’25
n/a
CHF 115.62
0%
15.4%
CHF 148.87
CHF 64.06
n/a
38
May ’25
CHF 98.50
CHF 115.14
+16.9%
15.2%
CHF 150.78
CHF 64.88
n/a
40
Apr ’25
n/a
CHF 116.55
0%
15.9%
CHF 156.52
CHF 62.43
n/a
38
Mar ’25
CHF 106.82
CHF 112.07
+4.9%
16.9%
CHF 152.16
CHF 60.69
n/a
37
Feb ’25
CHF 94.16
CHF 105.73
+12.3%
19.0%
CHF 143.22
CHF 64.71
n/a
35
Jan ’25
n/a
CHF 101.17
0%
25.9%
CHF 194.14
CHF 63.31
n/a
36
Dec ’24
CHF 88.45
CHF 99.72
+12.7%
28.2%
CHF 203.27
CHF 57.45
n/a
36
Nov ’24
n/a
CHF 106.06
0%
28.9%
CHF 208.80
CHF 68.09
n/a
35
Oct ’24
n/a
CHF 167.61
0%
18.2%
CHF 238.94
CHF 103.97
CHF 97.18
33
Sep ’24
n/a
CHF 170.22
0%
16.2%
CHF 230.71
CHF 105.67
CHF 104.50
32
Aug ’24
n/a
CHF 173.48
0%
17.8%
CHF 264.29
CHF 117.36
n/a
32
Jul ’24
n/a
CHF 219.26
0%
16.0%
CHF 283.72
CHF 147.68
n/a
34
Jun ’24
n/a
CHF 227.90
0%
17.2%
CHF 308.99
CHF 149.51
n/a
34
May ’24
n/a
CHF 232.10
0%
13.6%
CHF 304.78
CHF 147.48
CHF 98.50
34
Apr ’24
n/a
CHF 263.41
0%
14.3%
CHF 333.62
CHF 164.53
n/a
32
Mar ’24
n/a
CHF 273.19
0%
14.7%
CHF 343.06
CHF 169.18
CHF 106.82
29
Feb ’24
n/a
CHF 271.43
0%
15.5%
CHF 331.69
CHF 172.66
CHF 94.16
26
Jan ’24
n/a
CHF 293.79
0%
15.7%
CHF 352.90
CHF 176.92
n/a
29
Dec ’23
n/a
CHF 287.25
0%
15.2%
CHF 340.14
CHF 178.03
CHF 88.45
27
Nov ’23
n/a
CHF 301.20
0%
15.2%
CHF 359.98
CHF 188.42
n/a
26
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.